Brokerages Set GSK plc (LON:GSK) PT at GBX 1,842.50

Shares of GSK plc (LON:GSK) have earned a consensus recommendation of “Moderate Buy” from the seven research firms that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating on the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is GBX 1,842.50 ($23.89).

Several analysts have issued reports on GSK shares. Berenberg Bank restated a “buy” rating and issued a GBX 1,820 ($23.60) target price on shares of GSK in a research note on Tuesday, September 10th. Shore Capital reiterated a “buy” rating on shares of GSK in a research report on Wednesday, August 28th. JPMorgan Chase & Co. reissued an “underweight” rating on shares of GSK in a research note on Monday, July 29th. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 1,850 ($23.99) price target on shares of GSK in a research note on Tuesday, September 3rd.

Insider Buying and Selling

In other GSK news, insider Elizabeth (Liz) McKee Anderson acquired 446 shares of the business’s stock in a transaction on Monday, September 23rd. The stock was bought at an average price of GBX 2,051 ($26.60) per share, for a total transaction of £9,147.46 ($11,862.87). In related news, insider Elizabeth (Liz) McKee Anderson bought 446 shares of the stock in a transaction on Monday, September 23rd. The stock was bought at an average price of GBX 2,051 ($26.60) per share, with a total value of £9,147.46 ($11,862.87). Also, insider Jonathan Symonds bought 7,150 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The stock was bought at an average price of GBX 1,394 ($18.08) per share, with a total value of £99,671 ($129,258.20). In the last quarter, insiders purchased 7,604 shares of company stock valued at $10,893,886. 1.61% of the stock is owned by corporate insiders.

GSK Trading Up 1.9 %

Shares of LON GSK opened at GBX 1,419.50 ($18.41) on Thursday. The stock has a market cap of £57.92 billion, a P/E ratio of 1,256.19, a price-to-earnings-growth ratio of 1.24 and a beta of 0.31. The company has a debt-to-equity ratio of 123.04, a quick ratio of 0.73 and a current ratio of 0.82. GSK has a 52-week low of GBX 1,371.40 ($17.78) and a 52-week high of GBX 1,823.50 ($23.65). The firm has a 50 day moving average price of GBX 1,541.78 and a two-hundred day moving average price of GBX 1,593.52.

GSK Dividend Announcement

The company also recently disclosed a dividend, which will be paid on Thursday, January 9th. Shareholders of record on Thursday, November 14th will be given a GBX 15 ($0.19) dividend. The ex-dividend date is Thursday, November 14th. This represents a dividend yield of 1.03%. GSK’s dividend payout ratio (DPR) is currently 5,309.73%.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.